Drugs targeting protease-activated receptor-4 improve the anti-thrombotic therapeutic window

被引：6
|
作者：
French, Shauna L. [1 ]
Hamilton, Justin R. [1 ]
机构：
[1] Monash Univ, Australian Ctr Blood Dis, L2,AMREP Bldg,Alfred Commercial Rd, Melbourne, Vic 3004, Australia
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2017年 / 5卷 / 23期
基金：
英国医学研究理事会;
关键词：
ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; ANTAGONIST VORAPAXAR; PLATELET ACTIVATION; INTERVENTION; INHIBITION; PREVENTION; TRIAL;
D O I：
10.21037/atm.2017.09.10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Protease-Activated Receptor 4 Uses Anionic Residues To Interact with α-Thrombin in the Absence or Presence of Protease-Activated Receptor 1
    Nieman, Marvin T.
    BIOCHEMISTRY, 2008, 47 (50) : 13279 - 13286
  • [32] Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells
    Bretschneider, E
    Kaufmann, R
    Braun, M
    Nowak, G
    Glusa, E
    Schrör, K
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (07) : 1441 - 1446
  • [33] Cathepsin G and Protease-Activated Receptor-4 (PAR-4) in Mucosal Inflammation of Gastroesophageal Reflux Disease (GERD)
    Kandulski, Arne
    Friedrichs, Daniela
    Wex, Thomas
    Monkemuller, Klaus
    Kuester, Doerthe
    Malfertheiner, Peter
    GASTROENTEROLOGY, 2011, 140 (05) : S627 - S627
  • [34] Protease-activated receptor 3 negatively regulates plasmin-mediated protease-activated, receptor 4 activation in platelets
    Mao, Yingying
    Jin, Jianguo
    Kunapuli, Satya P.
    BLOOD, 2007, 110 (11) : 1063A - 1063A
  • [35] High Glucose Upregulates Protease-Activated Receptor-4 (PAR-4) in Human Vascular Smooth Muscle Cells
    Dangwal, Seema
    Rauch, Bernhard
    Schroer, Karsten
    Rosenkranz, Anke
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E306 - E306
  • [36] Therapeutic potential of protease-activated receptor-1 antagonists
    Derian, CK
    Maryanoff, BE
    Zhang, HC
    Andrade-Gordon, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (02) : 209 - 221
  • [37] Combined deficiency of protease-activated receptor-4 and fibrinogen recapitulates the hemostatic defect but not the embryonic lethality of prothrombin deficiency
    Camerer, E
    Duong, DN
    Hamilton, JR
    Coughlin, SR
    BLOOD, 2004, 103 (01) : 152 - 154
  • [38] Mechanism of Race-Dependent Platelet Activation Through the Protease-Activated Receptor-4 and Gq Signaling Axis
    Tourdot, Benjamin E.
    Conaway, Stanley
    Niisuke, Katrin
    Edelstein, Leonard C.
    Bray, Paul F.
    Holinstat, Michael
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (12) : 2644 - 2650
  • [39] A Murine Monoclonal Antibody That Binds N-Terminal Extracellular Segment of Human Protease-Activated Receptor-4
    Sangawa, Takeshi
    Nogi, Terukazu
    Takagi, Junichi
    HYBRIDOMA, 2008, 27 (05): : 331 - 335
  • [40] Increased expression of protease-activated receptor-4 in human vascular smooth muscle cells in response to high glucose
    Dangwal, S.
    Jobi, K.
    Rauch, B. H.
    Schroer, K.
    Rosenkranz, A. C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 56 - 56
12345